Kelly JR
Psychiatry, University of Dublin Trinity College, Ireland.
ArticlePsychedelics
Implementing psychedelic-assisted therapy in Ireland: perspectives from a national stakeholder survey.
ArticlePsilocybin
Trials, trips, and tribulations: pathways for implementing psychedelic therapy in Ireland.
Article5-MeO-DMT
GH001 vs Placebo in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.
ArticlePsilocybin
The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis.
ArticlePsilocybin
Psychedelic therapy and postpartum depression: priorities and prospects.
ArticlePsilocybin
Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic Research.
ArticlePsilocybin
Psilocybin reporting in media (PRiMe) for the treatment of depression.
ArticlePsilocybin
Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].
ArticlePsychedelics
Narrating the psychoneuroimmunomodulatory properties of serotonin 5-HT<sub>2A</sub> receptor psychedelics from a transdiagnostic perspective.
ArticlePsilocybin
The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.
ArticlePsilocybin
Amid magic and menace: psychiatrists' attitudes to psilocybin therapy.
ArticlePsilocybin
Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication.
ArticlePsilocybin
Seeking the Psilocybiome: Psychedelics meet the microbiota-gut-brain axis.
ArticlePsilocybin
Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective.
ArticlePsilocybin
Psychedelic perceptions: mental health service user attitudes to psilocybin therapy.
ArticlePsilocybin